<DOC>
	<DOC>NCT00632008</DOC>
	<brief_summary>The purpose of this study is to determine whether the application of soluble beta-glucan (SBG) onto diabetic foot ulcers improves the healing of the ulcers.</brief_summary>
	<brief_title>Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Type 1 or Type 2 diabetes mellitus Age â‰¥ 18 years One or more fullthickness ulcers at or below the level of the malleoli, which do not extend to tendon, joint, or bone The ulcer (or index ulcer, if appropriate) must have been present for at least 4 weeks prior to Day 0 but not longer than 2 years Ankle:brachial pressure index (ABPI) &gt;0.7, or the presence of two palpable pulses on the affected foot Ulcer area &gt;25 mm2 but &lt;500 mm2 Written informed consent Pregnancy, lactation or absence of adequate contraception for women with child bearing capacity ABPI &lt; 0.7 Serum albumin &lt; 2.0 g/dL Gangrene on any part of the foot with the study ulcer Presence of signs of clinically significant foot infection on Day 0 Chronic renal failure with calculated GFR &lt;30 ml/min Surgical procedure (other than debridement) on the foot with the study ulcer in the 28 days prior to Day 0 HbA1c 12% or more Current alcohol or drug abuse Participation in other studies in the preceding 28 days An ulcer on a foot affected by acute Charcot osteoarthropathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>